Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: Report of 2 cases and review of the literature

Diagnostic Microbiology and Infectious Disease

Volumn 46, Issue 1, 2003, Pages 49-54

  Nannini, Esteban C ^a   Paphitou, Niki I ^a,b   Ostrosky Zeichner, Luis ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b JFB ^*  (Cyprus)

Author keywords

Aspergillus; Continuous ambulatory peritoneal dialysis; Mucor; Peritonitis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CASPOFUNGIN; CEFTRIAXONE;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; ASPERGILLUS TERREUS; BACTERIAL PERITONITIS; CANDIDA; CASE REPORT; CATHETER; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MEDICAL LITERATURE; MOULD; MUCOR; PRIORITY JOURNAL; SURVIVAL RATE; ZYGOMYCETES;

EID: 0038061829     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00554-0     Document Type: Article

References (56)

1. Adam R.D., Hunter G., DiTomasso J., Comerci G. Mucormycosis emerging prominence of cutaneous infections . Clin Infect Dis. 19:1994;67-76.
2. Agarwal S., Goodman N.L., Malluche H.H. Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 21:1993;673-675.
3. Ahmad S., Johnson R.J., Hillier S., Shelton W.R., Rinaldi M.G. Fungal peritonitis caused by Lecythophora mutabilis. J Clin Microbiol. 22:1985;182-186.
4. Amici G., Grandesso S., Mottola A., Virga G., Teodori T., Maresca M.C., Bocci C. Verticillium peritonitis in a patient on peritoneal dialysis. Am J Nephrol. 14:1994;216-219.
5. Arfania D., Everett E.D., Nolph K.D., Rubin J. Uncommon causes of peritonitis in patients undergoing peritoneal dialysis. Arch Intern Med. 141:1981;61-64.
6. Arikan S., Lozano-Chiu M., Paetznick V., Rex J.H. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother. 45:2001;327-330.
7. Arikan S., Lozano-Chiu M., Paetznick V., Rex J.H. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother. 46:2002;245-247.
8. Basok A., Schneider E., Hausmann M., Rapoport J. Aspergillus peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Nephrol. 20:2000;329-331.
9. Bibashi E., Papagianni A., Kelesidis A., Antoniadou R., Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant. 8:1993;185-187.
10. Branton M.H., Johnson S.C., Brooke J.D., Hasbargen J.A. Peritonitis due to Rhizopus in a patient undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis. 13:1991;19-21.
11. Bren A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis. 17:1998;839-843.
12. Canon H.L., Buckingham S.C., Wyatt R.J., Jones D.P. Fungal peritonitis caused by Curvularia species in a child undergoing peritoneal dialysis. Pediatr Nephrol. 16:2001;35-37.
13. Carpenter J.L., Foulks C.J., Weiner M.H. Peritoneal dialysis complicated by Aspergillus flavus peritonitis a role for fungal antigen serodiagnosis . Nephron. 32:1982;258-260.
14. Clark E.C., Silver S.M., Hollick G.E., Rinaldi M.G. Continuous ambulatory peritoneal dialysis complicated by Aureobasidium pullulans peritonitis. Am J Nephrol. 15:1995;353-355.
15. Dannaoui E., Borel E., Persat F., Piens M.A., Picot S. Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol. 49:2000;601-606.
16. del Rio Perez O., Santin Cerezales M., Manos M., Rufi Rigau G., Gudiol Munte F. Mucormycosis: a classical infection with a high mortality rate. Report of 5 cases. Rev Clin Esp. 201:2001;184-187.
17. Espinel-Ingroff A. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 36:1998;2950-2956.
18. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol. 39:2001;954-958.
19. Eucker J., Sezer O., Graf B., Possinger K. Mucormycoses. Mycoses. 44:2001;253-260.
20. Fergie J.E., Fitzwater D.S., Einstein P., Leggiadro R.J. Mucor peritonitis associated with acute peritoneal dialysis. Pediatr Infect Dis J. 11:1992;498-500.
21. Gadallah M.F., White R., el-Shahawy M.A., Abreo F., Oberle A., Work J. Peritoneal dialysis complicated by Bipolaris hawaiiensis peritonitis successful therapy with catheter removal and oral itraconazol without the use of amphotericin-B . Am J Nephrol. 15:1995;348-352.
22. Giacchino F., Belardi P., Merlino C., Aimino M., Garneri G., Cuffini A.M., Tullio V. Treatment of Fusarium peritonitis in a peritoneal dialysis patient. Perit Dial Int. 17:1997;403-404.
23. Goldberg S.L., Geha D.J., Marshall W.F., Inwards D.J., Hoagland H.C. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis. 16:1993;803-805.
24. Goldie S.J., Kiernan-Tridle L., Torres C., Gorban-Brennan N., Dunne D., Kliger A.S., Finkelstein F.O. Fungal peritonitis in a large chronic peritoneal dialysis population a report of 55 episodes . Am J Kidney Dis. 28:1996;86-91.
25. Horisberger J.D., Bille J., Waters J.P. Fungal eosinophilic peritonitis due to Alternaria in a patient on continuous ambulatory peritoneal dialysis. Periton Dial Bull. 4:1984;255-256.
26. Kelly S.E., Shaw S.E., Clark W.T. Long-term survival of four dogs with disseminated Aspergillus terreus infection treated with itraconazole. Aust Vet J. 72:1995;311-313.
27. Kravitz S.P., Berry P.L. Successful treatment of Aspergillus peritonitis in a child undergoing continuous cycling peritoneal dialysis. Arch Intern Med. 146:1986;2061-2062.
28. Lass-Florl C., Kofler G., Kropshofer G., Hermans J., Kreczy A., Dierich M.P., Niederwieser D. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother. 42:1998;497-502.
29. Lo W.K., Chan T.M., Lui S.L., Li F.K., Cheng I.K. Fungal peritonitis-current status 1998. Perit Dial Int. 19:1999;S286-S290.
30. Matsumoto N., Shiraga H., Takahashi K., Kikuchi K., Ito K. Successful treatment of Aspergillus peritonitis in a peritoneal dialysis patient. Pediatr Nephrol. 17:2002;243-245.
31. Michel C., Courdavault L., al Khayat R., Viron B., Roux P., Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol. 14:1994;113-120.
32. Miles A.M., Barth R.H. Aspergillus peritonitis: therapy, survival, and return to peritoneal dialysis. Am J Kidney Dis. 26:1995;80-83.
33. Nakamura M., Weil W.B., Kaufman D.B. Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis association with deferoxamine . Pediatr Nephrol. 3:1989;80-82.
34. National Committee for Clinical Laboratory Standards. (1998). Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
35. Nguyen M.H., Muder R.R. Aspergillus peritonitis in a continuous ambulatory peritoneal dialysis patient. Case report and review of the literature. Diagn Microbiol Infect Dis. 20:1994;99-103.
36. Oakley K.L., Moore C.B., Denning D.W. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob Agents Chemother. 41:1997;1124-1126.
37. Oakley K.L., Moore C.B., Denning D.W. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. Antimicrob Agents Chemother. 43:1999;1264-1266.
38. Perez-Fontan M., Rodriguez-Carmona A., Fernandez-Rivera C., Moncalian-Leon J. Aspergillus peritonitis complicating continuous ambulatory peritoneal dialysis. Nephron. 57:1991;493-494.
39. Peterson P.K., Matzke G., Keane W.F. Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis. 9:1987;604-612.
40. Pfaller M.A., Messer S.A., Hollis R.J., Jones R.N. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi report from SENTRY Antimicrobial Surveillance Program, 2000 . Antimicrob Agents Chemother. 46:2002;1032-1037.
41. Polo J.R., Luno J., Menarguez C., Gallego E., Robles R., Hernandez P. Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 13:1989;237-239.
42. Prewitt K., Lockard J., Rodgers D., Hasbargen J. Successful treatment of Aspergillus peritonitis complicating peritoneal dialysis. Am J Kidney Dis. 13:1989;501-503.
43. Rodriguez-Tudela J.L., Barros C., Aguado J.M., Gomez-Garces J.L., Velo M., de Arriba G. Aspergillus niger peritonitis. Nephrol Dial Transplant. 3:1988;232.
44. Ross D.A., Anderson D.C., Macnaughton M.C., Stewart W.K. Fulminating disseminated aspergillosis complicating peritoneal dialysis in eclampsia. Arch Intern Med. 121:1968;183-188.
45. Sarcia-Ruiz J.C., Alvarez C., Floristan F., Hernandez I., Hernandez J., Alvarez Blanco A., Ponton J. Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia. Sangre (Barc). 38:1993;399-402.
46. Shin J.H., Lee S.K., Suh S.P., Ryang D.W., Kim N.H., Rinaldi M.G., Sutton D.A. Fatal Hormonema dematioides peritonitis in a patient on continuous ambulatory peritoneal dialysis criteria for organism identification and review of other known fungal etiologic agents . J Clin Microbiol. 36:1998;2157-2163.
47. Sridhar R., Thornley-Brown D., Kant K.S. Peritonitis due to Aspergillus niger diagnostic importance of peritoneal eosinophilia . Perit Dial Int. 10:1990;100-101.
48. Stein M., Levine J.F., Black W. Successful treatment of Aspergillus peritonitis in an adult on continuous ambulatory peritoneal dialysis. Nephron. 59:1991;145-147.
49. Sun Q.N., Fothergill A.W., McCarthy D.I., Rinaldi M.G., Graybill J.R. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother. 46:2002;1581-1582.
50. Sun Q.N., Najvar L.K., Bocanegra R., Loebenberg D., Graybill J.R. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother. 46:2002;2310-2312.
51. Sutton D.A., Sanche S.E., Revankar S.G., Fothergill A.W., Rinaldi M.G. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol. 37:1999;2343-2345.
52. Tanis B.C., Verburgh C.A., van 't Wout J.W., van der Pijl J.W. Aspergillus peritonitis in peritoneal dialysis: case report and a review of the literature. Nephrol Dial Transplant. 10:1995;1240-1243.
53. Tsai T.J., Chen Y.M., Hsieh B.S., Chen W.Y., Yen T.S. Can intracatheter retention of antifungal agents cure fungal peritonitis. Two cases successfully treated without catheter removal. Perit Dial Int. 11:1991;355-356.
54. Vas S.I. Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int. 23:1983;83-92.
55. Vlassopoulos D., Kouppari G., Arvanitis D., Papaefstathiou K., Dounavis A., Velegraki A., Hadjiconstantinou V. Wangiella dermatitidis peritonitis in a CAPD patient. Perit Dial Int. 21:2001;96-97.
56. Wang A.Y., Yu A.W., Li P.K., Lam P.K., Leung C.B., Lai K.N., Lui S.F. Factors predicting outcome of fungal peritonitis in peritoneal dialysis analysis of a 9-year experience of fungal peritonitis in a single center . Am J Kidney Dis. 36:2000;1183-1192.